189 related articles for article (PubMed ID: 21114870)
21. Regional variation in surgical assessment of lymph nodes for staging among women with early-stage epithelial ovarian cancer.
Ulanday KT; Ward KK; Macera CA; Ji M; Plaxe SC
Gynecol Oncol; 2014 Feb; 132(2):411-5. PubMed ID: 24246773
[TBL] [Abstract][Full Text] [Related]
22. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A
Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
[TBL] [Abstract][Full Text] [Related]
23. Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer.
Nomura H; Tsuda H; Susumu N; Fujii T; Banno K; Kataoka F; Tominaga E; Suzuki A; Chiyoda T; Aoki D
Int J Gynecol Cancer; 2010 Apr; 20(3):341-5. PubMed ID: 20375794
[TBL] [Abstract][Full Text] [Related]
24. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer.
Pereira A; Magrina JF; Rey V; Cortes M; Magtibay PM
Gynecol Oncol; 2007 Jun; 105(3):604-8. PubMed ID: 17321572
[TBL] [Abstract][Full Text] [Related]
25. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
[TBL] [Abstract][Full Text] [Related]
26. The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: A population-based study.
Zhou J; Zhang WW; Zhang QH; He ZY; Sun JY; Chen QH; Wu SG
Int J Surg; 2018 Apr; 52():11-15. PubMed ID: 29432972
[TBL] [Abstract][Full Text] [Related]
27. Is lymphadenectomy necessary in mucinous ovarian cancer? A single institution experience.
Salgado-Ceballos I; Ríos J; Pérez-Montiel D; Gallardo L; Barquet-Muñoz S; Salcedo-Hernández R; Pérez-Plasencia C; Herrera LA; Cantú de León DF
Int J Surg; 2017 May; 41():1-5. PubMed ID: 28315410
[TBL] [Abstract][Full Text] [Related]
28. Lymphadenectomy for early-stage mucinous ovarian carcinoma.
Heyward QD; Nasioudis D; Cory L; Haggerty AF; Ko EM; Latif N
Int J Gynecol Cancer; 2021 Jan; 31(1):104-109. PubMed ID: 33243777
[TBL] [Abstract][Full Text] [Related]
29. Ovarian cancer: lymph node metastases.
Balbi G; Manganaro MA; Monteverde A; Landino I; Franzese C; Gioia F
Eur J Gynaecol Oncol; 2009; 30(3):289-91. PubMed ID: 19697623
[TBL] [Abstract][Full Text] [Related]
30. Contralateral pelvic and aortic lymph node metastasis in clinical stage I epithelial ovarian cancer.
Walter AJ; Magrina JF
Gynecol Oncol; 1999 Jul; 74(1):128-9. PubMed ID: 10385564
[TBL] [Abstract][Full Text] [Related]
31. Lymph node metastasis in stages I and II ovarian cancer: a review.
Kleppe M; Wang T; Van Gorp T; Slangen BF; Kruse AJ; Kruitwagen RF
Gynecol Oncol; 2011 Dec; 123(3):610-4. PubMed ID: 21982047
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer.
Ataseven B; Grimm C; Harter P; Prader S; Traut A; Heitz F; du Bois A
Gynecol Oncol; 2014 Dec; 135(3):435-40. PubMed ID: 25312398
[TBL] [Abstract][Full Text] [Related]
33. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
[TBL] [Abstract][Full Text] [Related]
34. Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables.
Ayhan A; Gultekin M; Taskiran C; Celik NY; Usubutun A; Kucukali T; Yuce K
Gynecol Oncol; 2005 May; 97(2):400-4. PubMed ID: 15863136
[TBL] [Abstract][Full Text] [Related]
35. The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer.
Bachmann C; Brucker SY; Kraemer B; Rothmund R; Staebler A; Fend F; Wallwiener D; Grischke EM
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1475-80. PubMed ID: 25739827
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer.
Gouy S; Goetgheluck J; Uzan C; Duclos J; Duvillard P; Morice P
Eur J Surg Oncol; 2012 Feb; 38(2):170-5. PubMed ID: 22104389
[TBL] [Abstract][Full Text] [Related]
37. Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic Lymphadenectomy.
Heitz F; Harter P; Ataseven B; Heikaus S; Schneider S; Prader S; Bommert M; Fisseler-Eckhoff A; Traut A; du Bois A
Ann Surg Oncol; 2018 Jul; 25(7):2053-2059. PubMed ID: 29633097
[TBL] [Abstract][Full Text] [Related]
38. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.
Yavuzcan A; Baloglu A; Cetinkaya B
Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011
[TBL] [Abstract][Full Text] [Related]
39. [Our and foreign experience in surgical staging of early ovarian cancer].
Ivanov C
Akush Ginekol (Sofiia); 2011; 50(2):19-22. PubMed ID: 21913568
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic value of lymphadenectomy in ovarian cancer patients].
Gmyrek L; Jońska-Gmyrek J; Żółciak-Siwińska A
Ginekol Pol; 2014 Oct; 85(10):788-91. PubMed ID: 25546932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
